Healthcare Sector

HUMA

Market Tracker

$1.30
+0.02
(+1.56%)
9:40 pm
Next Earnings: (est.) 08/12/23 12:00 am
  • HUMA (Selected)

    Humacyte, Inc.

HUMA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

HUMA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

HUMA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

HUMA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

HUMA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/17/2026 CALL $2.00 1,216 +583 +92.10%
09/18/2026 CALL $2.50 1,085 +530 +95.50%
06/18/2026 CALL $2.00 1,814 +331 +22.32%
06/18/2026 PUT $1.00 1,681 +187 +12.52%
12/18/2026 CALL $1.50 119 +100 +526.32%
01/21/2028 CALL $2.00 3,533 +91 +2.64%
01/21/2028 CALL $0.50 2,028 -1 -0.05%
01/21/2028 CALL $1.00 4,451 -2 -0.04%
09/18/2026 CALL $1.50 861 -3 -0.35%
09/18/2026 CALL $2.00 569 -5 -0.87%
01/21/2028 CALL $2.50 4,382 -10 -0.23%
01/15/2027 CALL $2.00 7,265 -26 -0.36%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

HUMA Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 1.43% 1.48M 4.72M
iShares Russell 2000 ETF 1.06% 1.09M 3.48M
Vanguard Extended Market Index Fund 0.75% 770.08k 2.46M
iShares Russell 2000 Growth ETF 0.41% 427.99k 1.37M
iShares NASDAQ Biotechnology ETF 0.41% 420.07k 1.34M
Fidelity Small Cap Index Fund 0.34% 350.79k 1.12M
Fidelity Extended Market Index Fund 0.24% 248.66k 793.22k
Schwab Strategic Tr-Schwab U.S. Small Cap ETF 0.20% 210.69k 672.09k
Vanguard Health Care Index Fund 0.19% 193.94k 618.67k
Schwab Capital Trust-Small Cap Index Fund 0.13% 131.72k 420.19k

HUMA News

  • Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update

    05/13 07:00 am

    GlobeNewswire Inc.

    Read more
  • Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer

    05/12 08:00 am

    GlobeNewswire Inc.

    Read more
  • Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

    03/27 07:00 am

    GlobeNewswire Inc.

    Read more
  • Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair

    12/22 09:00 am

    GlobeNewswire Inc.

    Read more
  • Strong Earnings and Biotech Resilience Define the Midweek Momentum

    11/12 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback

    09/18 03:08 pm

    Benzinga

    Read more
  • Humacyte Posts Q2 Revenue Miss

    08/11 07:20 am

    The Motley Fool

    Read more
  • US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

    03/26 06:18 am

    Benzinga

    Read more
  • DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

    01/21 11:44 am

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    01/17 01:28 pm

    Benzinga

    Read more
  • HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

    01/17 11:47 am

    GlobeNewswire Inc.

    Read more
  • Humacyte, Inc. (HUMA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

    01/13 01:14 pm

    Benzinga

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    01/13 11:08 am

    Benzinga

    Read more
  • HUMA DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

    01/11 05:14 pm

    GlobeNewswire Inc.

    Read more
  • HUMA INVESTOR ALERT: Kirby McInerney LLP Reminds Humacyte, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

    01/10 12:00 pm

    GlobeNewswire Inc.

    Read more
  • HUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    01/06 05:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

    01/05 02:23 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT for PACS, HAS, ASML, HUMA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

    01/03 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Humacyte, Inc. (HUMA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

    01/02 05:06 pm

    Benzinga

    Read more
  • DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Humacyte to Contact Us to Have Their Losses Evaluated Today

    12/31 10:21 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/30 07:54 pm

    GlobeNewswire Inc.

    Read more
  • Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. Lawsuit – HUMA

    12/30 01:58 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT for PACS, HAS, ASML, HUMA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

    12/27 01:36 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, NATIONAL TRIAL LAWYERS, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/26 03:41 pm

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

    12/26 01:32 pm

    Benzinga

    Read more
  • HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc.

    12/24 04:58 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A LONGSTANDING FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/23 11:55 pm

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    12/23 11:27 am

    Benzinga

    Read more
  • ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/20 11:58 pm

    GlobeNewswire Inc.

    Read more
  • US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone'

    12/20 06:37 am

    Benzinga

    Read more
  • Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

    12/19 11:47 pm

    GlobeNewswire Inc.

    Read more
  • HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

    12/19 10:00 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

    12/19 08:23 pm

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

    12/19 02:26 pm

    Benzinga

    Read more
  • Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Humacyte, Inc. (HUMA)

    12/12 01:56 pm

    GlobeNewswire Inc.

    Read more
  • Humacyte’s (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman

    12/12 12:48 pm

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

    12/11 08:21 pm

    Benzinga

    Read more
  • Investors in Humacyte, Inc. Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your Rights – HUMA

    12/11 02:00 pm

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT for PACS, HAS, ASML, HUMA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

    12/10 07:49 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/06 11:56 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    12/03 06:41 pm

    GlobeNewswire Inc.

    Read more
  • 全球頂尖法律事務所 ROSEN 鼓勵 Humacyte, Inc. 投資者在對 HUMA 提出證券集體訴訟的重要截止日期之前聘請律師

    11/30 02:49 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    11/30 02:49 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA

    11/27 08:15 pm

    GlobeNewswire Inc.

    Read more
  • HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit

    11/27 04:38 pm

    Benzinga

    Read more
  • SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

    11/26 06:44 pm

    GlobeNewswire Inc.

    Read more
  • HUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    11/26 05:00 pm

    GlobeNewswire Inc.

    Read more
  • The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 – HUMA

    11/26 02:20 pm

    GlobeNewswire Inc.

    Read more
  • HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm

    11/25 10:00 pm

    GlobeNewswire Inc.

    Read more
  • Humacyte, Inc. Shareholder Alert: Robbins LLP Reminds Investors of the HUMA Securities Class Action

    11/24 01:23 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: